I nsulin-dependent diabetes mellitus (IDDM)
2 is caused by the progressive autoimmune destruction of the insulin-producing ␤ cells of the pancreatic islets of Langerhans, leading to insulin deficiency and hyperglycemia (1) . The use of animal models such as the nonobese diabetic (NOD) mouse, which spontaneously develops diabetes with many of the features of human disease, has greatly enhanced our understanding of the pathogenesis of autoimmune diabetes (2, 3) .
Accumulating experimental evidence indicates that programmed cell death, or apoptosis, represents an important mechanism of islet ␤ cell destruction in NOD diabetes, although the predominant molecular pathways responsible remain unresolved. Apoptotic ␤ cell death is detected in the islets of female NOD mice from the age of 3 wk, and the highest level of ␤ cell apoptosis is observed at week 15, which coincides with the earliest onset of diabetes (4) . Various studies have alternatively implicated Fas ligand (FasL), perforin, or TNF as effectors of apoptotic islet cell death (5) (6) (7) (8) (9) (10) (11) . For example, inbred Fas-, perforin-, or TNFR-deficient NOD mice display a reduced incidence and delayed onset of clinical diabetes relative to their wild-type counterparts (6 -8, 10) . TNF-␣ has alternately been reported to either promote disease progression or exert a protective effect on NOD diabetes, in a manner that appears to depend on the age of the animal (9, 12, 13) .
We have previously reported a role for Fas/FasL-mediated programmed cell death in the progression of NOD diabetes, based on the observations that: 1) Fas-deficient NOD (NOD-lpr/lpr) mice fail to develop diabetes; and 2) the incidence of diabetes is markedly reduced following transfer of diabetogenic T cells into irradiated NOD-lpr/lpr mice (6) . These results have since been supported by the observations of induced islet ␤ cell Fas expression that correlates with disease onset, in both wild-type NOD mice and diabetic patients (5, 14) .
The most direct interpretation of our findings in the NOD-lpr/lpr model is that Fas-expressing islet cells are destroyed by FasL-expressing autoimmune effector cells. However, this interpretation is complicated by the abnormal immune phenotype of NOD-lpr/lpr animals, which is characterized by the development of diffuse lymphadenopathy and the population of the peripheral lymphoid tissue by large numbers of CD4
ϩ (DN) TCR␣␤ T cells expressing high levels of FasL (15, 16) . The presence of these cells could both impair the natural development of islet specific autoimmunity and disrupt the function of adoptively transferred diabetogenic T cells. Indeed, recent studies using Fas-deficient islets in transplant models have suggested only a minor role for the Fas/FasL pathway in islet cell destruction during diabetes pathogenesis (17) .
In this report, we examine the role of Fas-mediated apoptosis in NOD diabetes using several newly derived genetically inbred mouse strains. First, the development of diabetes was examined in NOD mice rendered either heterozygous or homozygous for the mutated FasL gene gld (NOD-gld/gld mice). Second, adoptive transfer studies were performed using NOD-lpr/lpr mice into whom the scid mutation had been introduced (NOD-lpr/lpr-scid/ scid mice) as recipients. In this fashion, the ability of diabetogenic T cells to transfer disease could be assessed in recipient animals with deficient expression of Fas on their islets but also free of the large numbers of FasL-expressing DN host T cells that could impair the function of the adoptively transferred cells. The results from both experimental models provide strong evidence that Fas/ FasL mediated programmed cell death plays a significant role in the pathogenesis of autoimmune diabetes.
Materials and Methods

Generation of NOD-lpr/lpr, NOD-gld/gld, and NOD-lpr/lpr-scid/ scid mice
Fas-deficient MRL/MpJ-lpr/lpr mice (The Jackson Laboratory, Bar Harbor, ME) were crossed with NOD/LtJ mice (The Jackson Laboratory), and the lpr gene was backcrossed to NOD for seven generations and then intercrossed as previously described (6) .
FasL-deficient C3H/HeJ-gld/gld mice (The Jackson Laboratory) were crossed with NOD/LtJ mice, and the gld gene was backcrossed to NOD for six generations and then intercrossed. The gld genotype was determined by PCR on tail DNA using a pair of primers (5Ј-CAG CAG CCC AAA GCT TTA TG-3Ј, 5Ј-CTC AAC TCT CTC TGA TCA ATT TTG AGG A-3Ј). The 320-bp PCR products were then digested with StuI (New England BioLabs, Beverly, MA) at 37°C overnight and resolved on a 1.2% Nusieve agarose gel (FMC BioProducts, Rockland, ME). The digestion yielded a 280-bp and a 40-bp fragment for the wild-type allele, whereas StuI does not digest the 320-bp PCR product for the mutated allele.
NOD-lpr/lpr, NOD-lpr/ϩ, NOD-gld/gld, and NOD-gld/ϩ mice and their NOD-wt intercross littermates were typed for polymorphic microsatellites linked to the IDDM susceptibility (Idd) genes. Among the increasing number of Idd genes linked to IDDM, we tested the susceptibility-linked markers Idd1, Idd3, Idd5, Idd10, and Idd16, which have been shown to be required for the development of both insulitis and diabetes (2) . Microsatellite markers were selected from the published data (8, 18) and the database released by the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research (Cambridge, MA). Primers that can distinguish polymorphisms among NOD, MRL, and C3H strains were selected and listed as follows: Idd1, D17 Mit83; Idd3, D3 Mit270; Idd5, D1 Mit318; Idd10, D3 Mit140; and Idd16, D17 Mit50. The microsatellite markers were amplified by PCR from tail DNA with primers. The PCR products were resolved on 5% Nusieve agarose gels. Tail DNA samples from NOD/LtJ, MRL/MpJ-lpr/lpr, and C3H/HeJ-gld/gld mice were used as controls. Samples without template DNA were used as negative controls in each experiment.
In all studies, 5-wk-old female littermates of different genotypes derived from the lpr breeding and gld breeding were monitored for the spontaneous development of IDDM for a period of 30 wk.
NOD-lpr/lpr mice were crossed with NOD/LtSz-scid/J mice (The Jackson Laboratory), and the lpr/ϩ and scid/ϩ heterozygotes were then intercrossed to generate NOD-lpr/lpr-scid/scid and NOD-scid/scid littermate mice. The lpr and scid genotypes were determined as previously described (15, 19) .
Diabetes
Mice were observed for the onset of diabetes with measurements of urine glucose using Chemstrip 2 GP urine test strips (Boehringer Mannheim, Indianapolis, IN) at least twice a week. The glucose concentration in blood obtained from a tail vein was measured using ExacTech blood glucose test strips (MediSense, Medford, MA). Consecutive readings of blood glucose levels Ͼ250 mg/dl (13.9 mmol) was considered diagnostic of diabetes onset.
Adoptive transfer of diabetes
Adoptive cell transfer was performed as previously described (20) . The spleens from diabetic female NOD/LtJ mice were harvested, and 4 ϫ 10 7 splenocytes were injected into a tail vein of 8-to 12-wk-old male NOD-wt, NOD-lpr/lpr, NOD-gld/gld, or 8-to 12-wk-old male or female NOD-scid/ scid or NOD-lpr/lpr-scid/scid littermate mice. NOD-wt, NOD-lpr/lpr, and NOD-gld/gld recipient mice were irradiated at 800 rad 1 day before the transfer of splenocytes.
For the isolation of CD4 ϩ and CD8 ϩ T cells, single-cell suspensions of splenocytes from NOD-lpr/lpr and NOD-gld/gld mice were run through columns packed with anti-B220-coated Sepharose beads to remove B220 ϩ DN T cells. The CD4 ϩ or CD8 ϩ T cells were then prepared via high affinity negative selection, following the procedure suggested by the manufacturer (R&D Systems, Minneapolis, MN). The purity of recovered CD4 ϩ or CD8 ϩ T cells was Ͼ 95% as indicated by flow cytometry analysis. In cell cotransfer experiments, 2 ϫ 10 7 spleen cells from diabetic female NOD mice were injected into a tail vein of NOD/LtSz-scid/J mice either alone or together with 2 ϫ 10 7 spleen cells (CD4 ϩ , CD8 ϩ , or unseparated) from NOD-gld/gld or NOD-lpr/lpr mice.
Flow cytometry
Heparinized peripheral blood of the mice was lysed with ACK lysis buffer (Biofluids, Rockville, MD) for 10 min at room temperature. After a washing with FACS buffer (HBSS with 5% FCS and 0.02% sodium azide), cells were stained with biotinylated hamster anti-mouse TCR ␤-chain (clone: H57-597), Fas (clone: Jo2), or B220 Ab (clone: 6B2) (PharMingen), followed by combination of fluorescein isothiocyanate (FITC)-conjugated rat anti-mouse CD4 (clone: GK1.5) and CD8 (clone: 53-6.7) or rat anti-mouse CD45 (clone: 30-F11) Ab (PharMingen, San Diego, CA), and streptavidin-PE (Southern Biotechnology Associates, Birmingham, AL). Viable cells were analyzed by flow cytometry on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA) with logarithmic scales. CellQuest software (Becton Dickinson) was used for the analysis of the data.
Histological examination
Pancreata were dissected from the mice and fixed in 10% formalin. Sections were obtained from paraffin-embedded tissue samples and stained with hematoxylin and eosin. For NOD-scid/scid and NOD-lpr/lpr-scid/scid recipient mice, sections of pancreas were scored for the degree of insulitis, and the number of islets was counted. Insulitis was scored as follows: 0, normal; 1, periinsulitis; 2, noninvasive mononuclear cell infiltration in Ͻ50% of the area of the islet; 3, invasive mononuclear cell infiltration in 50% or more of the area of the islet; 4, loss of islet morphology. Insulitis with a score of 1 or 2 was considered as nondestructive, whereas insulitis with a score of 3 or 4 was considered as destructive.
Immunohistochemistry
The pancreata were fixed overnight in 10% formalin and embedded in paraffin. Tissue sections 4 m thick were sectioned and deparaffinized. The endogenous peroxidase activity was quenched by 3% hydrogen peroxidemethanol for 10 min at room temperature. After a washing with PBS, the slides were incubated with Beat Blocking Solution A (Zymed Laboratories, South San Francisco, CA) for 30 min at room temperature, followed by a washing with PBS. The slides were then incubated with rabbit anti-human glucagon (DAKO, Carpinteria, CA) or guinea pig anti-human insulin Ab (DAKO) in a humidified chamber for 2 h at room temperature, followed by biotinylated anti-rabbit or anti-guinea pig Ig Ab (Zymed) for 30 min and peroxidase-avidin conjugate (Zymed) for 10 min. The slides were washed with PBS and stained with substrate-chromogen mixture at room temperature for ϳ5-10 min. The color reaction was terminated by repeated washes in distilled water. The slides were counterstained with hematoxylin for 1-2 min and then dried and mounted with coverslips.
FasL-dependent cytotoxicity assay
Cytolysis of the Fas-positive A20 murine B lymphocyte cell line in a [ 3 H]thymidine release assay was used to measure FasL activity by a method highly similar to a previously published study (21) . Fresh isolated unfractionated lymph node cells were used as effector cells. In other experiments, lymph node effector cells were stimulated with Con A (5 g/ml) for 24 h before coculture with A20 cells. The A20 cells (5 ϫ 10 4 ) were labeled with [ 3 H]thymidine (Amersham, Arlington Heights, IL) for 2 h at 37°C and then incubated with 50 g/ml hamster anti-mouse Fas Ab (clone: Jo2) (PharMingen) or freshly isolated lymph node cells from mice in quadruplicate at an E:T ratio of 40:1 in the presence or absence of 20 g/ml anti-FasL Ab (clone: Kay-10, PharMingen) in round-bottom 96-well microtiter plates at 37°C. After 12 h of incubation, intact cells were harvested using a Micro 96 harvester (Tomtec, Hamden, CT) and the associated radioactivity was measured on a liquid scintillation counter (Wallac, Gaithersburg, MD). Because we measure the radioactivity retained by intact cells, the minimum radioactivity retained by the samples treated with bleach corresponds to the maximum release described in assays measuring radioactivity in supernatants (16) , whereas the cpm in the cell samples cultured in medium alone without effector killer cells measures in effect the inverse of the spontaneous release of radioactivity by 
Statistical analysis
Student t tests assuming two samples with unequal variance were performed with the Microsoft Excel 97 data analysis program. A two-tail p value is represented.
Results
Phenotypic characterization of NOD-lpr and NOD-gld mice and analysis of spontaneous development of diabetes
We as well as other groups have reported that Fas-deficient NOD mice (NOD-lpr/lpr) fail to develop diabetes (6, 7) . Surprisingly, the islets of these animals manifest no insulitis and are generally free of any inflammatory cells (6, 7) . To further investigate the role of Fas/FasL interactions in the development of NOD diabetes, we crossed NOD mice with C3H-gld/gld mice, backcrossed the gld gene to NOD mice for six generations, and then intercrossed. The resulting NOD-gld/gld mice, like the NOD-lpr/lpr mice, developed lymphadenopathy and abundant peripheral CD4 Ϫ CD8 Ϫ T cells by 4 mo of age (Fig. 1A) . However, in contrast to NOD-lpr/ lpr cells, which have markedly reduced levels of Fas expression, NOD-gld/gld T cells express normal levels of Fas (Fig. 1B) .
We determined the incidence of spontaneous diabetes in NODgld/gld and NOD-lpr/lpr mice, as well as in NOD mice heterozygous for the lpr and gld mutations, relative to wild-type NOD-wt littermate mice. By the age of 35 wk, 70% (7 of 10) of female NOD-wt mice developed diabetes, whereas none of the NOD-lpr/ lpr (0 of 8) females developed disease ( Fig. 2A) , consistent with previous results (6, 7). Interestingly, there was a delayed onset and reduced incidence of diabetes (3 of 7, or ϳ40%) in heterozygous NOD-lpr/ϩ mice at the same age ( Fig. 2A) . Although the average percentage of Fas-expressing CD4 ϩ CD8 ϩ blood cells from these Fas heterozygous animals was similar (77%, n ϭ 7) to that of NOD-wt mice (96%, n ϭ 5), the average intensity of cell surface Fas expression, represented by the mean channel fluorescence, was significantly reduced in NOD-lpr/ϩ mice (51.1, n ϭ 7) compared with NOD-wt mice (100.8, n ϭ 5, p Ͻ 0.001) (Fig. 1B) . The NOD-lpr/ϩ animals did not accumulate greatly increased numbers of DN T cells in the periphery (Fig. 1A) . Histological examination revealed moderate to severe insulitis in the pancreata of nondiabetic NOD-lpr/ϩ mice (Fig. 2C) . As expected, a high percentage of Fasexpressing CD4 ϩ
CD8
ϩ cells was also observed in both NOD-gld/gld mice (average, 93%; n ϭ 2) and NOD-gld/ϩ mice (average, 92%; n ϭ 2). The average intensity of cell surface Fas expression was 124.8 in NOD-gld/gld mice (n ϭ 2) vs 120 in NOD-gld/ϩ mice (n ϭ 2) (Fig. 1B) .
Analogous to the NOD-lpr/lpr mice, none of the NOD-gld/gld mice (0 of 6) exhibited elevated glucose levels by 35 wk of age. Histological examination of pancreata of these animals showed little to no mononuclear cell infiltration (Fig. 2B ), again analogous to what is observed in age-matched NOD-lpr/lpr mice (data not shown). In contrast, there was severe insulitis with the destruction of islet ␤ cells in the pancreata of diabetic 35-wk-old NOD-wt littermate mice (data not shown). Thus, both NOD-lpr/lpr and NOD-gld/gld mice do not spontaneously develop either insulitis or diabetes at an age when a majority of wild-type littermates have developed disease.
Interestingly, none of the NOD-gld/ϩ mice (0 of 6) developed diabetes by 35 wk of age ( Fig. 2A) . As expected, peripheral lymphoid cells from these animals expressed normal levels of Fas (Fig.  1B ), but unlike their gld homozygous counterparts, they do not accumulate increased numbers of DN T cells (Fig. 1A) . Histologically, the NOD-gld/ϩ animals could be distinguished from NODgld/gld homozygous animals by the presence of pancreatic mononuclear cell infiltrates characteristic of noninvasive insulitis (Fig.  2D) . From these observations, it may be inferred that islet-specific T cells are in fact generated in NOD-gld/ϩ mice but fail to progress to destructive insulitis and diabetes.
Two lines of evidence indicated that the reduced incidence of diabetes in the NOD mice heterozygous for the lpr and gld mutations was due to altered expression of fas and fasL, and not to background genetic variation. First, all of the wild-type NOD mice used in these studies, manifesting a high incidence of spontaneous diabetes, were littermates of the animals expressing mutant fas and fasL alleles, and thus products of the identical genetic crosses. Second, all the mice utilized in these experiments were genotyped for polymorphic microsatellites linked to the IDDM susceptibility (Idd) genes. Idd1, Idd3, Idd5, Idd10, and Idd16, which have shown significant evidence of linkage to the development of both insulitis and diabetes (2), were tested. Microsatellite markers were amplified by PCR from genomic DNA with primers and the products of the reaction were analyzed on the agarose gels (Fig. 3) . Our genetic screening revealed that all NOD-lpr/lpr, NOD-lpr/ϩ, and their NOD wild-type littermates carried homozygous NOD alleles at Idd1, Idd3, Idd5, Idd10, and Idd16 loci. Similarly, all NOD-gld/ gld, NOD-gld/ϩ mice, and their NOD littermate controls carried homozygous NOD alleles at all five Idd loci, with the exception of one litter from this intercross, which carried heterozygous or wildtype alleles at the Idd10 locus. These latter mice were deleted from Ϫ cells among peripheral blood TCR ϩ T cells is 9.5% in NOD-wt mice (n ϭ 5), 23.8% in NOD-lpr/ϩ mice (n ϭ 7), 62.6% in NOD-lpr/lpr mice (n ϭ 4), 58.1% in NOD-gld/gld mice (n ϭ 2), and 5.6% in NOD-gld/ϩ mice (n ϭ 2). B, Decreased Fas expression in peripheral T cells of NOD-lpr/lpr mice. Representative two-color flow cytometric analysis of Fas expression of peripheral blood T cells in NOD-wt, NOD-lpr/ϩ, NOD-lpr/lpr, NODgld/ϩ, and NOD-gld/gld mice is shown. CD4 ϩ /CD8 ϩ cells were gated and analyzed for the levels of Fas expression. The average percentage of Fas expression on CD4 ϩ /CD8 ϩ cells is 96% in NOD-wt mice (n ϭ 5), 76.8% in NOD-lpr/ϩ mice (n ϭ 7), 17.3% in NOD-lpr/lpr mice (n ϭ 4), 93.2% in NOD-gld/gld mice (n ϭ 2), and 91.9% in NOD-gld/ϩ mice (n ϭ 2), with the average intensity, represented by the mean channel fluorescence, of 100.8, 51.1, 56.4, 124.8, and 119.8, respectively. The unshaded peak represents control staining, and the shaded peak represents staining with the indicated Ab. the analysis, despite the fact that the wild-type offspring from this cross developed diabetes at the same rate and incidence as fully inbred wild type NOD-wt mice (data not shown). Furthermore, no diabetes susceptibility loci have been mapped in proximity to the fas or fasL genes, making it unlikely that protective alleles would have segregated with the lpr or gld genotypes (2, (22) (23) (24) (25) . The IDDM susceptibility (Idd) genes in NOD-wt, NOD-lpr/ϩ, NOD-lpr/lpr, NOD-gld/ϩ, and NOD-gld/gld littermates. The microsatellite markers Idd1, Idd3, Idd5, Idd10, and Idd16 were amplified by PCR using tail DNA from NOD-lpr/ϩ, NOD-lpr/lpr, NOD-gld/ϩ, and NOD-gld/gld mice and their NOD-wt littermates. The primers, which were selected to distinguish polymorphisms at each Idd locus among NOD, MRL, and C3H strains, are indicated. Tail DNA samples from NOD/LtJ, MRL/MpJ-lpr/lpr, and C3H/HeJ-gld/gld mice were used as controls. The PCR products were resolved on 5% Nusieve agarose gels. The fragment sizes of NOD were indicated.
Diabetes in NOD-lpr/lpr and NOD-gld/gld mice after adoptive cell transfer
We performed adoptive cell transfer experiments to determine the ability of polyclonal spleen cell populations from diabetic NOD mice to transfer disease to nondiabetic recipient animals (20) . Splenocytes from diabetic NOD mice were transferred to sublethally irradiated NOD-wt, NOD-lpr/lpr, or NOD-gld/gld mice, and the development of diabetes after cell transfer was determined. As shown in Fig. 4 , 100% of NOD-wt recipient mice (12 of 12) developed diabetes by day 25 after transfer of diabetogenic spleen cells. Confirmatory of previously reported findings (6, 7), none of the NOD-lpr/lpr mice developed diabetes by 35 days after transfer. In contrast, 50% (3 of 6) of the NOD-gld/gld mice became diabetic by 28 days after cell transfer, and by day 35 the incidence of diabetes in these animals was 100%. Consistent with the clinical findings, severe insulitis with the destruction of islet morphology was observed in the pancreata of both NOD-wt and NOD-gld/gld littermates injected with diabetic NOD spleen cells (data not shown). In contrast, the islets of the NOD-lpr/lpr recipient mice were free of mononuclear cell infiltration (data not shown), similar to the results in previous reports (6, 7) . The moderate delay in onset of diabetes in the NOD-gld/gld recipients could have been due to the presence in the peripheral lymphoid tissue of these animals of large numbers of relatively radioresistant lymphocytes (26) , thus delaying colonization by the adoptively transferred cells. Genetic resistance of the gld homozygous hosts seemed an unlikely explanation, as the wild-type recipients were all littermates of these gld mice.
The development of diabetes in irradiated NOD-gld/gld recipient mice but not NOD-lpr/lpr hosts is consistent with the capacity for Fas expression on islets in the former but not the latter strain of mice after autoreactive cell transfer. Also, the successful adoptive transfer of diabetes to the gld recipients indicates that the presence of large DN cell populations and lymphadenopathy in the host per se could not alone explain the failure of NOD-lpr/lpr recipients to develop disease. However, a critical difference between the DN T cells of lpr and gld mice is the expression of large amounts of functional FasL on the surface of the DN NOD-lpr/lpr T cells (16) . We therefore considered the possibility that activated Fas-expressing autoreactive T cells from the NOD donors were selectively eliminated by FasL-expressing host DN cells in the NOD-lpr/lpr recipients after adoptive transfer, thus accounting for their failure to at least infiltrate the host islets. The recently reported radioresistance of Fas-deficient lymphoid cells added further credence to this scenario (26) .
Apparent sensitivity of islet-specific autoreactive cell populations to Fas-mediated apoptosis
In preliminary experiments, we observed persistent DN T cells populating lymphoid organs of NOD-lpr/lpr mice for as long as 7 days after irradiation (data not shown), consistent with the reported radioresistance of this Fas-deficient population (26) . To assess the potential role of these cells in influencing disease induction, we performed experiments wherein diabetogenic cells from wild-type NOD mice were cotransferred to recipient NOD/LtSz-scid/J animals together with various spleen cell populations from NOD-lpr/ lpr or NOD-gld/gld mice. The incidence of diabetes in the various groups of NOD/LtSz-scid/J recipient mice was then evaluated (Fig. 5) . As expected, Ͼ80% (13 of 16) of the NOD/LtSz-scid/J mice became diabetic by 35 days after injection of diabetogenic spleen cells from wild-type NOD mice alone (Fig. 5) . In contrast, only 33% (5 of 15) of NOD/LtSz-scid/J recipients developed diabetes by 38 days after cotransfer of wild-type NOD splenocytes together with whole spleen cell populations from NOD-lpr/lpr mice (Fig. 5) . A high frequency of diabetes was observed after cotransfer of diabetic NOD splenocytes together with either purified CD4
ϩ (85%, 6 of 7) or CD8 ϩ (83%, 5 of 6) splenocytes from NOD-lpr/lpr donors, suggesting that the DN T cells in the NODlpr/lpr mice were predominantly responsible for the partial protection against disease transfer. Because the DN T cells from lpr ) from NOD mice were transferred i.v. into irradiated NOD-wt, NOD-lpr/lpr, and NOD-gld/gld mice. Mice were followed for 35 days with measurements of urine glucose every other day. The number of observed mice per group is shown in parentheses. Statistical analysis indicates significant differences in the time to onset of diabetes between the NOD-wt recipient mice and NOD-gld/gld recipient mice (p Ͻ 0.01). A significant difference (p Ͻ 0.01) in time to onset was also found between the NOD-wt recipient mice and NOD-lpr/lpr recipient mice. animals express markedly elevated levels of FasL (16), it was possible that these cells could be blocking disease induction by eliminating diabetogenic NOD T cells via Fas/FasL interactions. This possibility was supported by the observation that transfer of diabetes was unimpaired when diabetogenic NOD spleen cells were cotransferred with whole spleen cell populations from FasL-deficient NOD-gld/gld mice (Fig. 5) .
Reconstitution of NOD-lpr/lpr-scid/scid mice with diabetogenic NOD spleen cells
To evaluate whether host FasL-expressing cells alone accounted for the failure to adoptively transfer diabetes to NOD-lpr/lpr recipient mice, NOD-lpr/lpr mice were crossed with NOD/LtSzscid/J mice and then intercrossed to produce NOD mice homozygous for both lpr and scid mutations (NOD-lpr/lpr-scid/scid). Mice homozygous for both lpr and scid gene mutations were identified by PCR screening and confirmed by flow cytometry. As shown in Fig. 6 , the number of cells expressing the leukocyte marker CD45 that were either TCR ϩ or B220 ϩ were markedly reduced in both NOD-scid/scid and NOD-lpr/lpr-scid/scid animals relative to wild-type NOD mice.
It was next important to establish that this dramatic reduction in TCR ϩ cells in the scid/lpr mice had resulted in a reduction in FasL-mediated lytic activity in these animals. To demonstrate that such a reduction in FasL-dependent endogenous apoptotic activity was accomplished by crossing the scid mutation into the NODlpr/lpr strain, killing assays were performed as previously described (21) to analyze the ability of lymph node cells to lyse Fas ϩ A20 target cells (Fig. 7) . The sensitivity of A20 cells to Fas-mediated lysis was illustrated by the ability of the anti-Fas Ab Jo2 to induce a high level of A20 cell death (Fig. 7) . NOD-lpr/lpr lymph node cells mediated a significant level of A20 cell lysis, consistent with their high level expression of FasL (16) . The FasL dependence of the A20 cell killing was demonstrated by the fact that most of the NOD-lpr/lpr lymph node-induced A20 cell death was inhibited in the presence of an anti-FasL Ab (Fig. 7) . In contrast to the potent lytic activity of the Fas-deficient NOD-lpr/lpr lymph node cells, lymph node cell populations from the NOD-lpr/lprscid/scid mice mediated no significant A20 killing (Fig. 7) . Furthermore, no significant Fas-dependent A20 killing was mediated by wild-type NOD, NOD-scid/scid, or FasL-deficient NOD-gld/ gld lymph node cells in this assay (Fig. 7) . The killing induced by NOD-scid/scid cells in the experiment shown was not at all inhibited by anti-FasL Ab and was thus not Fas/FasL dependent.
A modified, more sensitive form of this assay using lectinactivated lymphoid cells to mediate FasL-dependent killing was performed to demonstrate reduced apoptotic activity mediated by NOD-gld/ϩ cells relative to NOD-wt cells. This would be expected because the number of functional FasL homotrimers should be markedly reduced (by Ͼ85%) in cells expressing the mutant gld allele in heterozygous fashion. In this assay, lymph node cells were activated with Con A (5 g/ml) for 24h before coculture with A20 cells. Relative to Con A-activated NOD-wt lymph node cells, FasL-dependent killing by gld/ϩ cells was reduced by Ͼ75% (data not shown).
Having demonstrated that the endogenous FasL-mediated cytotoxic activity of NOD-lpr/lpr mice was abolished by introduction of the scid mutation, we next performed studies to evaluate the efficacy of adoptive transfer of diabetes to NOD-lpr/lpr-scid/scid mice. Spleen cells from diabetic NOD mice were administered as before to both NOD-lpr/lpr-scid/scid mice as well as to their NOD-scid/scid littermates. Phenotypic analysis was performed on peripheral blood cells from these animals both before and 45 days after diabetic NOD spleen cell transfer (Fig. 8) . Before adoptive transfer of diabetic NOD spleen cells, the small number of residual Absence of FasL-mediated lytic activity in the lymph node cells of NOD-lpr/lpr-scid/scid mice. FasL-dependent cytotoxicity assays were performed as described in Materials and Methods. Lymph node cells isolated from NOD-wt, NOD-lpr/lpr, NOD-gld/gld, NOD-scid/scid, and NOD-lpr/lpr-scid/scid mice were used as effector cells, whereas [ 3 H]thymidine-labeled Fas ϩ A20 B cells were used as targets. The cells were incubated at an E:T ratio of 40:1 at 37°C for 12 h in the presence or absence of 20 g/ml anti-FasL mAb (anti-FasL). The cells were harvested and specific lysis was then calculated. To demonstrate the susceptibility of A20 cells to Fas-mediated lysis, a control cytotoxicity assay was also performed by incubating [ TCR ϩ cells in scid and scid/lpr mice were comprised of similar percentages of CD4 and CD8 T cells (Fig. 8A ). Among these residual cells, Fas expression was normal in the scid and very low in the lpr/scid NOD mice, as expected (Fig. 8B) . Forty-five days after transfer of diabetic NOD spleen cells, similar percentages of adoptively transferred CD4 ϩ and CD8 ϩ T cells were present in both groups of recipient animals, as evidenced by the significant increase of TCR ϩ CD4 ϩ /CD8 ϩ and Fas ϩ CD4 ϩ /CD8 ϩ cells detected in the periphery (Fig. 8) . Equivalent absolute numbers of donor Fas ϩ CD4 ϩ /CD8 ϩ cells were also recovered from peripheral lymphoid tissue of recipient NOD-lpr/lpr-scid/scid and NOD-scid/scid mice (data not shown), indicating that significant elimination of donor cells had not occurred after adoptive transfer, in contrast to what has been shown in NOD-lpr/lpr hosts (17) . The donor origin of the Fas ϩ cells in the NOD-lpr/lpr-scid/scid mice after cell transfer is indicated by the near complete absence of such cells in these animals pretransfer (Fig. 8B) .
Diabetes in NOD-lpr/lpr-scid/scid mice after adoptive transfer of diabetogenic spleen cells
Having shown that both NOD-scid/scid and NOD-lpr/lpr-scid/scid mice were similarly reconstituted with donor splenic T cells from diabetic NOD mice, we evaluated the development of diabetes in these animals. Approximately 60% of NOD-scid/scid recipient mice were diabetic by day 25 posttransfer, which increased to 90% by 35 days (Fig. 9A) . In contrast, only 14% (1 of 7) of the NODlpr/lpr-scid/scid mice developed diabetes by 35 days after transfer, with only 2 of 7 NOD-lpr/lpr-scid/scid mice becoming diabetic by day 50 (Fig. 9A) . Histological analysis revealed more severe mononuclear infiltrates and a significantly higher percentage of islets with invasive, destructive insulitis in pancreata from NODscid/scid vs NOD-lpr/lpr-scid/scid recipient mice evaluated at equivalent time points after adoptive transfer (Fig. 9B) . Destructive insulitis was observed in ϳ90% of the islets in the NOD-scid/ scid recipients, in comparison with only 45% of the islets in NODlpr/lpr-scid/scid recipient mice ( p ϭ 0.025, Fig. 9B ). Immunohistochemistry revealed both insulin-producing ␤ cells and glucagon-producing ␣ cells in the islets of NOD-lpr/lpr-scid/ scid recipient mice (Fig. 9, C and D) , whereas only residual ␣ cells were detected in the pancreata of NOD-scid/scid mice after cell transfer (Fig. 9, E and F) . In summary, NOD-lpr/lpr-scid/scid recipient mice displayed both delayed onset and reduced incidence of diabetes, as well as decreased overall severity of insulitis relative to their Fas-expressing NOD-scid/scid littermates, after adoptive transfer of diabetogenic spleen cells.
Discussion
In the immune system, programmed cell death has been shown to play a critical role in both T and B cell development as well as in the homeostatic regulation of mature peripheral lymphoid populations (27) . In particular, apoptotic signaling through the TNF family receptor Fas (CD95) and its ligand (CD95L) is central to the regulation of mature lymphocyte growth and differentiation (28) . This is evidenced by the abnormal peripheral lymphocyte expansion and multiple autoimmune manifestations of mice or humans bearing mutant forms of either Fas or its ligand (15, 24, 25, 29 -32) .
Recent studies have identified additional roles for Fas/FasL interactions in the regulation of peripheral immunity, such as the mediation of immune privilege in various tissues, and as a potential effector pathway of target organ damage in the pathogenesis of autoimmune disease (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) . In the former instance the expression of FasL in certain tissues such as the testis or eye has been proposed to confer immune privilege via the elimination of Fasexpressing infiltrating lymphocytes (33) (34) (35) . A similar mechanism has been invoked to explain evasion of immune surveillance by tumors that selectively express FasL (36 -39) . With respect to autoimmunity, constitutive or induced Fas expression on various tissues renders them susceptible to destruction by FasL-expressing inflammatory cells. Such Fas/FasL-mediated apoptotic damage has been implicated in the pathogenesis of a number of autoimmune or inflammatory conditions, including diabetes, multiple sclerosis, thyroiditis, myocarditis, hepatitis, and gastritis (6, 7, 40 -48) .
The data presented in this study provide fresh evidence supporting a role for Fas-mediated apoptosis in the pathogenesis of autoimmune diabetes. The first line of evidence was provided by the surprising observation that NOD mice heterozygous for the FasL mutation gld failed to develop diabetes. These animals, unlike their NOD-gld/gld homozygous counterparts, did not develop lymphadenopathy or abnormal DN T cell populations but did manifest noninvasive insulitis, indicating that they had in fact generated an islet-specific immune response. Because FasL is a homotrimer (49) , the heterozygous expression of the mutant gld allele should result in a marked reduction in the number of functional cell surface FasL molecules. This notion is supported by our preliminary results which indicate that FasL-mediated killing activity of Con A-stimulated lymph node cells from NOD-wt mice was markedly greater than that of lymph node cells from NOD-gld/ϩ animals (data not shown). The failure of NOD-gld/ϩ animals to develop diabetes despite the presence of islet-infiltrating lymphocytes could therefore reflect a defect in FasL-mediated target cell damage and thus implicate Fas/FasL interactions in the progression from noninvasive insulitis to ␤ cell destruction and hyperglycemia.
The second major line of evidence for the role of islet-expressed Fas in disease pathogenesis was the reduced incidence and severity of diabetes in NOD-lpr/lpr-scid/scid recipients of spleen cells from diabetic NOD mice. The introduction of the scid mutation reduced peripheral lymphoid populations in NOD-lpr/lpr-scid/scid mice to levels equivalent to those of NOD-scid/scid littermates and abolished the FasL-mediated lytic activity that had been observed in NOD-lpr/lpr animals. Therefore, the reduced disease incidence in NOD-lpr/lpr-scid/scid vs NOD-scid/scid littermate recipients of diabetic NOD spleen cells most likely reflected the diminished ␤ cell Fas expression in the lpr/scid double mutants.
A variety of independent evidence supports a role for Fas/FasL interactions in the pathogenesis of IDDM (5-7, 14, 50 -54) . For instance, proinflammatory cytokines known to be associated with diabetes progression, such as IL-1␤, TNF-␣, and IFN-␥, have been shown to induce Fas expression on islet ␤ cells (5, 50 -54) . A correlation of ␤ cell destruction with Fas expression was recently reported in a syngeneic islet transplant model in NOD mice (14) . In this model, administration of CFA to NOD hosts was shown to protect transplanted NOD islets from destructive insulitis, whereas transplanted ␤ cells were destroyed in control grafted syngeneic animals treated with PBS. In this system, Fas was expressed only on ␤ cells in the rejecting islets, whereas equal numbers of FasLexpressing CD4 and CD8 graft-infiltrating T cells were present in both normal and rejecting islets.
Studies with human islets have shown that IL-1␤, via the generation of nitric oxide, selectively induces Fas expression in ␤ cells but not in other pancreatic endocrine cells, and that these ␤ cells are thus rendered sensitive to Fas-mediated destruction (5). In vivo FIGURE 9. Delayed onset and decreased incidence of diabetes in NOD-lpr/lpr-scid/scid mice receiving diabetogenic NOD T cells. A, Cumulative incidence of adoptively transferred diabetes in NOD-scid/scid and NOD-lpr/lpr-scid/scid mice. Diabetogenic NOD spleen cells (4 ϫ 10 7 ) were transferred i.v. into NOD-scid/scid and NOD-lpr/lpr-scid/scid mice. Mice were followed for 50 days with measurements of urine glucose every other day. The number of observed mice per group is shown in parentheses. Statistical analysis indicates significant difference of the diabetic onset time between the NOD-scid/scid recipient mice and NOD-lpr/lpr-scid/scid recipient (p Ͻ 0.001) ; B, Decreased severity of insulitis in NOD-lpr/lpr-scid/scid recipient mice after NOD spleen cell adoptive transfer. Single sections of pancreas from individual NOD-lpr/lpr-scid/scid and NOD-scid/scid recipient mice were examined under ϫ20 power, and the total number of islets was counted and scored for the degree of insulitis. The analysis was performed in a blinded manner. A total of 9 NOD-scid/scid and 5 NOD-lpr/lpr-scid/scid mice were evaluated. The percentages of normal islets, islets with nondestructive insulitis, and islets with destructive insulitis are shown. Destructive insulitis was observed in ϳ90% of the islets in the NOD-scid/scid recipients, in comparison with only 45% of the islets in NOD-lpr/lpr-scid/scid recipient mice (p ϭ 0.025). C, Insulin staining of pancreatic islets from NOD-lpr/lpr-scid/scid recipient mice. D, Glucagon staining of pancreatic islets from NOD-lpr/lpr-scid/scid recipient mice. E, Insulin staining of pancreatic islets from NOD-scid/scid recipient mice. F, Glucagon staining of pancreatic islets from NOD-scid/scid recipient mice. C-F, ϫ140.
histopathological analysis has shown recently that ␤ cells from the pancreata of newly diagnosed diabetics, but not ␤ cells from normal human pancreas, express Fas and undergo extensive apoptosis in proximity to FasL-expressing islet-infiltrating T cells (5) .
However, although our data demonstrate a role for Fas/FasL interactions in progression to diabetes, they also suggest the involvement of other inflammatory pathways in disease pathogenesis. This is illustrated principally by the development of insulitis and diabetes in a proportion of the Fas-deficient NOD-lpr/lpr-scid/ scid recipients of diabetic NOD mouse spleen cells. Results from various NOD-related disease models have provided evidence for a number of potentially important pathogenic mechanisms. Thus, at least two additional death effector systems apart from Fas/FasL, perforin and TNF/TNFR1, have been implicated in islet ␤ cell destruction. Like NOD-lpr/lpr and NOD-gld/gld mice, perforindeficient NOD mice also display a delayed onset and reduced incidence of diabetes (8) . It has been proposed that CD8 ϩ T cells lyse ␤ cells predominantly via perforin-dependent cytotoxicity (10) , although a recent study has identified a diabetogenic CD8 ϩ cell line that lyses ␤ cells exclusively via the Fas pathway (55) . The roles of TNF-␣ and its receptors (TNFR1 and TNFR2) in diabetes pathogenesis are more complex. Thus, in neonatal NOD mice, TNF accelerates disease whereas TNF inhibition is protective (9, 12); in contrast, local expression of TNF in the islets in adult life prevents disease whereas anti-TNF treatment of adult NOD mice exacerbates diabetes (9, 13) . Further, TNFR1-deficient NOD mice develop insulitis but fail to progress to diabetes, and when sublethally irradiated they display delayed onset of diabetes after adoptive transfer of diabetic NOD spleen cells (10) . The complex nature of TNF function in diabetes pathogenesis is further underscored in a study involving transplantation of islets bearing various genetic mutations into transgenic mice bearing an isletspecific class II MHC-restricted TCR transgene (11) . Transplanted TNFR1-deficient islets were protected from CD4 T cell-mediated destruction, but it appeared that TNFR1 expressed on ␤ cells promoted their destruction not directly via TNF-mediated programmed cell death but rather indirectly via the activation of the islet-infiltrating CD4 T cells. Indeed, the ability of CD4 T cells alone to induce diabetes despite the absence of class II MHC expression on ␤ cells originally inspired the proposal that ␤ cell destruction could also be mediated indirectly via the elaboration of proinflammatory soluble mediators such as the cytokines IFN-␥, IL-1, TNF-␣, and IL-6 or nitric oxide (56 -65) .
Interestingly, we (unpublished data) and others (11, 17) have observed that Fas-deficient NOD islets transplanted into diabetic NOD mice are destroyed, albeit somewhat more slowly than their wild-type NOD islet counterparts. In the context of the data in this report, it may be speculated that different mechanisms predominate in the destruction of ectopically transplanted islet grafts relative to ␤ cells in situ.
Taken together, the results of our study and of other models indicate that the pathogenesis of autoimmune diabetes is multifactorial, consistent with a process defined by distinct stages and the involvement of multiple different effector cell populations. Further, there are likely to be significant functional interactions among the distinct inflammatory pathways, as, for example, the induction of Fas expression and sensitivity in ␤ cells by the IL-1␤-stimulated production of nitric oxide (5) . It is also probable that distinct mechanisms and cell types predominate at different points in the disease process (66, 67) . Finally, it is also possible that different pathways may have a greater role in different individuals, perhaps influenced in part by genotypic differences or by the inciting autoantigen. For instance, Fas/FasL interactions have been demonstrated to play a major role in the pathogenesis of experimental autoimmune encephalitis, in a manner highly analogous to our findings in the NOD diabetes model (40 -43) . However, this effect appears to be strain specific, such that experimental autoimmune encephalitis is markedly attenuated in Fas-or FasL-deficient B6 (H-2 b ) mice immunized with a myelin oligodendrocyte glycoprotein MOG peptide (41) , as well as in Fas/FasL-deficient B10.PL (H-2 u ) mice challenged with myelin basic protein (40) , but progresses with severity equivalent to wild-type animals in Fas/FasL-deficient SJL/J (H-2 s ) mice induced with proteolipid protein (68) . Elucidating the roles played by distinct inflammatory pathways in diabetes pathogenesis could lead to more effective, targeted therapies for this disease.
A final implication of our data is the apparent sensitivity of autoreactive T cells themselves to Fas-mediated cell death. The insulitis observed in the NOD-lpr/lpr-scid/scid recipients of diabetic NOD T cells contrasted with the complete absence of cellular infiltrates after adoptive transfer to NOD-lpr/lpr hosts, suggesting that FasL-mediated elimination of islet-specific T cells occurred in the latter animals. This is consistent with the previously shown reduced survival of adoptively transferred T cells in unirradiated NOD-lpr/lpr mice (17) . In addition, FasL-mediated lysis of emerging islet-specific autoreactive T cells could also explain the inability of T cell populations from NOD-lpr/lpr mice to transfer diabetes to wild-type NOD or NOD-scid/scid recipients (data not shown). In principle, the sensitivity of autoreactive T cells to programmed cell death could also be exploited therapeutically in diabetes as well as other T cell-mediated autoimmune diseases (69) .
